一项方法学综述识别出利用注册登记系统开展随机对照试验的多种可选方案
该研究系统检索PubMed截至2023年2月2日的RRCT,纳入162项(41项方案和121项研究),分析其设计特征、注册登记数据利用程度和局限性。研究发现RRCT多为多中心、大样本、长随访,注册登记数据利用程度差异大,存在编码错误、数据不完整和技术挑战等局限。作者认为RRCT缺乏统一方法学,未来应明确注册登记数据的使用目的和程度,并建立清晰的分类体系。
要点
- RRCT多为多中心试验(78.4%),样本量中位1787例,随访中位60个月,失访极少。
- 注册登记数据利用程度差异大,从仅用于长期监测到全面用于招募、终点收集和随访。
- 局限包括编码错误、数据不完整及链接失败或录入延迟等技术挑战。
核心结论
- 注册登记数据存在广泛的潜在使用选项和利用程度,但在许多情况下其潜力及获益未被充分利用。
- RRCT没有单一统一的设计方法学,注册登记系统能以多种方式支持RCT。
- 未来RRCT应明确使用注册登记数据的目的和程度,并需要清晰的RRCT定义和分类体系以促进对话和研究。
研究设计与样本
- 方法学综述,系统检索PubMed截至2023年2月2日的正在进行的和已发表的RRCT,纳入至少报告一个来自注册登记系统结局的研究,由两名评价者独立筛选,数据提取至标准化表格并进行描述性统计。
- 共纳入162项RRCT(41项方案和121项研究)。
主要发现
- 多数RRCT为多中心试验(n=127;78.4%),参与者数量大(中位数=1787;范围=41至683927),随访时间长(中位数=60个月;范围=1至367个月),失访极少。
- 参与者纳入标准大多定义宽泛,干预类型从外科手术到行为干预不等,近一半干预(46.9%)具有预防目的。
- 主要注册登记结局多为临床终点(40.1%)或主要临床事件的复合终点(30.9%),且可客观测量。
- 注册登记数据利用程度不同,从独家使用长期监测已发表数据到更全面地用于患者招募、终点收集和长期随访。
- 使用注册登记数据的局限包括潜在编码错误或数据不完整(例如轻度病例记录不足),以及需考虑技术挑战(例如链接失败或数据录入延迟)。
临床怎么用
- 作者认为未来RRCT应明确使用注册登记数据的目的和程度。
- 作者认为需要清晰的RRCT定义和分类体系以促进未来关于RRCT的对话和研究。
局限性
- 使用注册登记数据的局限包括潜在编码错误或数据不完整(例如轻度病例记录不足)。
- 需考虑技术挑战(例如链接失败或数据录入延迟)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Registry-based randomized controlled trials (RRCTs) can provide internally valid results in a real-world context at relatively low effort and cost. However, the main characteristics, the extent to which the registry is utilized (eg, proportion of data from registry) and registry-related limitations are not well characterized. This methodological review of RRCTs aims to analyze the trial design features, investigate potential usage options, and identify possible limitations of using registry data for randomized controlled trials (RCTs). STUDY DESIGN AND SETTING: A systematic search in PubMed for ongoing and published RRCTs was conducted up to February 2, 2023. Studies that reported at least one outcome derived from a registry were included. Study selection was independently performed by two reviewers. All data were extracted into a standardized table, and descriptive statistics were generated. RESULTS: We included 162 RRCTs (41 protocols and 121 studies). Most RRCTs were multicenter trials (n = 127; 78.4%) comprising a large number of participants (median = 1787; range = 41 to 683,927) and a long follow-up period (median = 60 months; range = 1 to 367 months) with a minimal loss to follow-up. The inclusion criteria of participants were mostly broadly defined. Types of interventions ranged from surgical procedures to behavioral interventions, and almost half of the interventions (46.9%) had a preventive purpose. The main registry outcome was mostly a clinical endpoint (40.1%) or a composite endpoint of major clinical events (30.9%) that was objectively measurable. We found different degrees of registry utilization, ranging from the exclusive use of long-term monitoring of previously published data to the more comprehensive registry utilization for patient recruitment, endpoint collection, and long-term follow-up. Limitations related to the use of registry data comprised potential coding errors or incomplete data (eg, due to under-recording of mild cases). In addition, technical challenges must be considered (eg, failed linkages or time-delayed data entry). CONCLUSION: A broad spectrum of potential usage options and usage extent of registry data exist. Our analysis suggests that in many cases, the potential of using registry data and thus their benefits were not fully utilized. In addition, the study illustrates that there is not a single, unified methodology for designing RRCTs but that registries can support RCTs in various ways. Therefore, future RRCTs should specify for what purposes and to what extent registries were utilized. Moreover, a clear definition and taxonomy of RRCTs appears necessary for facilitating future dialogue and research on RRCTs.
引用
- Urban L, Haller N, Pieper D, et al. A methodological review identified several options for utilizing registries for randomized controlled trials. J Clin Epidemiol. 2024. PMID: 39561941. doi:10.1016/j.jclinepi.2024.111614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。